论文部分内容阅读
我院自 2 0 0 0年 6～ 1 1月使用抗ＣＤ2 0 + 单克隆抗体 (商品名 :美罗华 )治疗 7例复发性淋巴瘤 ,现将结果报告如下。1 资料与方法1 .1 病例选择7例患者均系住院患者。男 6例 ,女 1例 ,年龄2 2～ 86岁 ,平均 5 3岁。病程 0 .5～ 1 5年。诊断标准和疗效标准参照文献〔1?
7 cases of recurrent lymphoma were treated with anti-CD20 + monoclonal antibody (product name: rituximab) in our hospital from June to January in 2000. The results are reported as follows. 1 Materials and Methods 1 .1 Case Selection 7 patients were hospitalized patients. 6 males and 1 females, aged 22 to 86 years old, with an average of 53 years old. Course of disease 0.5 ~ 15 years. Diagnostic criteria and efficacy criteria reference [1?